Rockefeller Saliva Test for COVID-19 Outperforms Commercial Swab Tests
The Rockefeller University | Sep 16, 2021
New study confirms that Darnell’s test performs as well, if not better, than FDA-authorized nasal and oral swab tests
Industry News
Scientists Model How Coronavirus Attaches Itself to Human Cells
Rochester Institute of Technology | Sep 14, 2021
Complex simulations show how coronavirus’s grip may tighten as variants evolve
Researchers Identify Mechanism Driving COVID-19 Mortality
University of Arizona | Aug 25, 2021
Researchers have identified what may be the key molecular mechanism responsible for COVID-19 mortality
More Genetic Markers for Inherited Testicular Cancer Identified
Perelman School of Medicine at the University of Pennsylvania | Jul 28, 2021
A new meta-analysis increased the number of genetic locations for disease by 40 percent
Routine Screening for BI-RADS Lesions on Automated Whole-Breast Ultrasound
American Roentgen Ray Society | Jul 16, 2021
Routine screening for BI-RADS 3 lesions reduces the recall rate and is unlikely to result in adverse outcome
Removing Confusion from Laboratory Competency
Clinical Lab Manager | Mar 26, 2021
Clinical Lab Manager and Darryl Elzie, PsyD, MHA, MT (ASCP), CQA (ASQ) discuss lab competency
Genetic Testing Cost Effective for Newly Diagnosed GIST
University of California - San Diego | Sep 29, 2020
More than 95 percent of patients eventually succumb to drug-resistant GIST, underscoring the importance of starting patients on the most effective available drug
NIAID Establishes Centers for Research in Emerging Infectious Diseases
National Institute of Allergy and Infectious Diseases, National Institute of Health | Sep 03, 2020
Global network to focus on spillover potential
Study of COVID-19 Patients Reveals Distinct 'Immunotypes'
American Association for the Advancement of Science | Jul 16, 2020
As the global COVID-19 pandemic continues, researchers continue to investigate the characteristics of the human immune response in fighting it
First Human Trial of COVID-19 Vaccines Finds It Is Safe, Induces Rapid Immune Response
The Lancet | Jun 01, 2020
The creation of an effective vaccine is seen as the long-term solution to controlling the COVID-19 pandemic